Get the Stockscreener App
0.5029
0.90%
0.0045
After Hours:
.50
-0.0029
-0.58%
Bolt Biotherapeutics Inc Stock (BOLT) Forecast
The Bolt Biotherapeutics Inc (BOLT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $12.82, representing a +2,450% increase from the current price of $0.5029. The highest analyst price target is $12.30, and the lowest is $13.35.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BOLT Price Target
Average 16.48
(+3,177% Upside)
Is Bolt Biotherapeutics Inc (BOLT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.17 | Neutral |
| STOCH(9,6) | 16.29 | Buy |
| STOCHRSI(14) | 36.12 | Neutral |
| MACD(12,26) | -0.0147 | Sell |
| ADX(14) | 16.01 | Neutral |
| William %R | -82.93 | Buy |
| CCI(14) | -51.20 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5134
Sell
|
0.5129
Sell
|
| MA20 |
0.5347
Sell
|
0.5245
Sell
|
| MA50 |
0.5503
Sell
|
0.5528
Sell
|
| MA100 |
0.5942
Sell
|
0.6019
Sell
|
| MA200 |
0.709
Sell
|
0.7058
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BOLT could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on BOLT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.17 indicates that BOLT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.29 indicates that BOLT is oversold. This indicates that BOLT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 36.12 indicates that BOLT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.01 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -51.2 indicates that BOLT is still oversold but not to an extreme extent.
Long-term BOLT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bolt Biotherapeutics Inc financial reports and earnings history, Bolt Biotherapeutics Inc (BOLT) stock could reach $29.62 by 2030, $116.51 by 2040 and $11.85 by 2050. See the projected annual prices until 2050 of the Bolt Biotherapeutics Inc stock below:
- Bolt Biotherapeutics Inc (BOLT) is expected to reach an average price of $9.9239 in 2035, with a high prediction of $11.78 and a low estimate of $10.02. This indicates an $1,873% rise from the last recorded price of $0.5029.
- Bolt Biotherapeutics Inc (BOLT) stock is projected to chart a bullish course in 2040, with an average price target of $115.05, representing an $22,776% surge from its current level. The forecast ranges from a conservative $115.18 to a sky-high $116.51.
- Our analysts predict Bolt Biotherapeutics Inc (BOLT) to jump 14,596% by 2045, soaring from $73.99 to an average price of $73.90, potentially reaching $76.88. While $73.99 is the low estimate, the potential upside is significant.
- Bolt Biotherapeutics Inc (BOLT) stock is expected to climb by 2050, reaching an average of $8.7397, a $1,638% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.85 and $8.7547, respectively, highlighting the market's uncertainty.
Bolt Biotherapeutics Inc Stock (BOLT) Year by Year Forecast
Bolt Biotherapeutics Inc Stock (BOLT) Price Forecast for 2025
Bolt Biotherapeutics Inc Stock (BOLT) is expected to reach an average price of $15.64 in 2025, with a high prediction of $19.61 and a low estimate of $11.66. This indicates an +3,009% rise from the last recorded price of $0.5029.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $13.51 | $13.35 | $12.30 | +2,585% |
| March, 2025 | $15.47 | $15.18 | $15.72 | +2,976% |
| April, 2025 | $19.03 | $15.29 | $19.50 | +3,683% |
| May, 2025 | $19.84 | $19.96 | $19.61 | +3,845% |
| June, 2025 | $19.55 | $19.72 | $19.43 | +3,788% |
| July, 2025 | $18.71 | $18.87 | $18.83 | +3,621% |
| August, 2025 | $18.56 | $18.58 | $18.46 | +3,590% |
| September, 2025 | $19.11 | $18.56 | $18.83 | +3,701% |
| October, 2025 | $17.66 | $18.01 | $18.58 | +3,413% |
| November, 2025 | $17.03 | $17.29 | $17.37 | +3,286% |
| December, 2025 | $16.09 | $16.15 | $16.84 | +3,099% |
Bolt Biotherapeutics Inc Stock (BOLT) Price Forecast for 2026
The predicted value for Bolt Biotherapeutics Inc (BOLT) in 2026 is set at an average of $12.01. Estimates vary from a peak of $15.59 to a trough of $8.4334, indicating an +2,289% surge from the present price of $0.5029.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.70 | $15.73 | $15.59 | +3,022% |
| February, 2026 | $15.20 | $15.21 | $15.54 | +2,923% |
| March, 2026 | $14.91 | $14.92 | $14.91 | +2,865% |
| April, 2026 | $14.17 | $14.25 | $14.65 | +2,718% |
| May, 2026 | $13.40 | $13.46 | $13.96 | +2,565% |
| June, 2026 | $12.91 | $13.03 | $13.21 | +2,466% |
| July, 2026 | $11.93 | $11.99 | $12.56 | +2,271% |
| August, 2026 | $11.21 | $11.34 | $11.70 | +2,129% |
| September, 2026 | $10.60 | $10.64 | $10.95 | +2,007% |
| October, 2026 | $9.7595 | $9.8595 | $10.35 | +1,841% |
| November, 2026 | $8.7115 | $8.9315 | $9.4875 | +1,632% |
| December, 2026 | $8.1514 | $8.4334 | $8.4774 | +1,521% |
Bolt Biotherapeutics Inc Stock (BOLT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bolt Biotherapeutics Inc (BOLT) is $4.2119, with a high forecast of $8.1073 and a low forecast of $0.3164. This indicates an +737.51% increase from the last price of $0.5029.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.8233 | $7.8333 | $8.1073 | +1,456% |
| February, 2027 | $7.2252 | $7.2552 | $7.5613 | +1,337% |
| March, 2027 | $6.6451 | $6.6451 | $7.0432 | +1,221% |
| April, 2027 | $6.037 | $6.1858 | $6.4331 | +1,100% |
| May, 2027 | $5.4789 | $5.4891 | $5.815 | +989.46% |
| June, 2027 | $4.7189 | $4.7589 | $5.267 | +838.33% |
| July, 2027 | $3.9008 | $4.0977 | $4.4969 | +675.66% |
| August, 2027 | $3.1727 | $3.2127 | $3.7288 | +530.89% |
| September, 2027 | $2.4226 | $2.5126 | $2.9307 | +381.73% |
| October, 2027 | $1.6546 | $1.7246 | $2.1106 | +229.00% |
| November, 2027 | $0.8165 | $1.0465 | $1.3125 | +62.35% |
| December, 2027 | $0.3014 | $0.3164 | $0.5304 | -40.07% |
Bolt Biotherapeutics Inc Stock (BOLT) Price Forecast for 2028
In 2028, Bolt Biotherapeutics Inc (BOLT) is projected to reach an average price of $21.96, with a high projection of $43.75 and a low estimate of $0.1644. This indicates an +4,266% rise from the last price of $0.5029.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $37.03 | $0.1644 | $29.67 | +7,264% |
| February, 2028 | $36.06 | $25.89 | $28.21 | +7,070% |
| March, 2028 | $36.08 | $32.63 | $36.64 | +7,074% |
| April, 2028 | $40.77 | $38.00 | $39.03 | +8,007% |
| May, 2028 | $40.76 | $42.55 | $41.39 | +8,005% |
| June, 2028 | $43.29 | $42.21 | $41.55 | +8,509% |
| July, 2028 | $42.42 | $43.95 | $43.18 | +8,334% |
| August, 2028 | $37.01 | $37.09 | $41.08 | +7,259% |
| September, 2028 | $39.00 | $38.34 | $38.91 | +7,655% |
| October, 2028 | $38.04 | $38.89 | $38.57 | +7,465% |
| November, 2028 | $40.20 | $39.05 | $40.62 | +7,894% |
| December, 2028 | $43.45 | $39.87 | $43.75 | +8,540% |
Bolt Biotherapeutics Inc Stock (BOLT) Price Forecast for 2029
The 2029 price forecast for Bolt Biotherapeutics Inc Stock (BOLT) is $36.61 on average, with a high prediction of $43.22 and a low estimate of $30.01. This represents an +7,180% increase from the previous price of $0.5029.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $43.12 | $43.40 | $43.22 | +8,474% |
| February, 2029 | $42.18 | $42.41 | $42.37 | +8,288% |
| March, 2029 | $41.13 | $41.17 | $41.30 | +8,078% |
| April, 2029 | $39.85 | $40.00 | $40.45 | +7,824% |
| May, 2029 | $39.64 | $39.57 | $39.46 | +7,782% |
| June, 2029 | $38.05 | $38.10 | $38.95 | +7,467% |
| July, 2029 | $36.44 | $36.67 | $37.35 | +7,145% |
| August, 2029 | $34.38 | $34.57 | $36.03 | +6,736% |
| September, 2029 | $33.58 | $33.60 | $33.83 | +6,577% |
| October, 2029 | $32.16 | $32.17 | $33.19 | +6,295% |
| November, 2029 | $31.22 | $31.23 | $31.71 | +6,109% |
| December, 2029 | $29.99 | $30.01 | $30.80 | +5,863% |
Bolt Biotherapeutics Inc Stock (BOLT) Price Forecast for 2030
Bolt Biotherapeutics Inc Stock (BOLT) is expected to reach an average price of $21.54 in 2030, with a high forecast of $29.62 and a low forecast of $13.46. This signifies an +4,183% surge from the last price of $0.5029.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $28.26 | $28.32 | $29.62 | +5,519% |
| February, 2030 | $27.11 | $27.23 | $27.90 | +5,291% |
| March, 2030 | $25.65 | $25.70 | $26.61 | +5,000% |
| April, 2030 | $24.33 | $24.46 | $25.27 | +4,738% |
| May, 2030 | $22.73 | $22.93 | $23.91 | +4,420% |
| June, 2030 | $21.44 | $21.58 | $22.37 | +4,164% |
| July, 2030 | $19.35 | $19.57 | $20.90 | +3,748% |
| August, 2030 | $18.36 | $18.43 | $18.93 | +3,550% |
| September, 2030 | $17.27 | $17.39 | $17.95 | +3,334% |
| October, 2030 | $15.76 | $15.79 | $16.87 | +3,034% |
| November, 2030 | $14.67 | $14.69 | $15.42 | +2,818% |
| December, 2030 | $13.44 | $13.46 | $14.31 | +2,572% |
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):